Beauty OEM Blog

Arbutin is the gentle tyrosinase inhibitor living in hydroquinone's shadow. Alpha vs beta, the working dose, and how the US, EU, UK and AU regulate brightening.

Astaxanthin from Haematococcus pluvialis is a real antioxidant, but '6,000x vitamin C' is an in-vitro number. Working dose, formulation and claim rules.

Clean has no legal definition. Build a clean beauty and fragrance line that clears retailer lists, IFRA standards and EU allergen rules, no misleading claims.

Sourcing cosmetics from China? EU CPNP, UK SCPN and US MoCRA duties: Responsible Person, US Agent, INCI labels, banned ingredients, factory checklist.

MoCRA puts safety substantiation on the Responsible Person. A step-by-step US path: deadlines, cosmetic vs drug wording, evidence tiers and real study costs.

A formulator's guide to private label eye care: typing dark circles and puffiness, evidence-backed actives, and US MoCRA, EU, UK and Australia rules.

How medspas and aesthetic clinics buy device-grade mask kits: three ODM routes, professional-use labelling, USD kit pricing, treatment bundling and margins.

A teardown of KANS Red Waistline: GHK-Cu formulation traps, why the kit model beats the single serum, and where the topical-Botox story stops being evidence.

Kans moved 16.5 million peptide kits on a self-developed cyclohexapeptide. What travels to Amazon and TikTok Shop, and what does not survive the crossing.

Is your post-laser mask a cosmetic or a medical device? A buyer's guide to FDA 510(k), EU MDR, UK and TGA routes, ISO 13485 factory checks and claim red lines.

Ceramides make up nearly 50% of the lipids in your skin barrier — the 'mortar' between skin cells. But 'higher concentration is better' is a myth: the 3:1:1 molar ratio with choles

Marubi Bio hit record revenue of ¥3.459B in 2025, main brand +23.94%, eye-care revenue ¥834M at 77.1% gross margin. The Red Pen eye cream topped 48 sub-category lists — powered by

Scalp care is becoming skincare. China's hair and scalp market hit ¥54.1B in 2025 (forecast ¥58.3B in 2026), anti-hair-loss grew +22.3% as the fastest segment, and global scalp ser

Back-to-school season is beauty OEM's next growth wave. Gen Z students want affordable, ingredient-transparent skincare — and a 500-unit MOQ makes private label entry faster than y

IP-collab gift sets, couple sets, and men's fragrance gifting are reshaping the beauty gift-box market. Here's how OEM factories capture holiday gifting demand with stable formulas

Does '5% niacinamide' really mean 5% in the formula? Can you legally write '7-day brightening' or 'repairs sensitive skin'? 8 high-frequency compliance questions on ingredient conc

Your lab sample was flawless, but the production run shifted in pH, colour and scent. This is the most common quality failure in cosmetic OEM. Here are the three root causes and th

A no-hype teardown of the single-dose ampoule category — why 'sterile, fresh, high-concentration' commands a premium, and the packaging/formula/compliance checklist every private-l

Astaxanthin is a lipid-soluble carotenoid from Haematococcus pluvialis with real antioxidant power — but the '6,000× vitamin C' ORAC claim is an in-vitro myth. Effective concentrat

The ignored increment: Chinese women over 50 now spend ¥38B+ on skincare, growing ~25% a year, yet penetration sits at just 12% (vs ~25% in Japan). Five data points and three OEM e

Eight high-frequency questions answered with evidence grades — budget private-label launch costs and MOQ, salicylic vs azelaic acid, the anti-glycation/collagen/NMN truth, and BPOM

Searches up 150% and facial-oil GMV growing 40%+: squalane and ceramide oils are turning 'oil nourishing' into 2026's breakout category. A no-hype teardown of the trend and three O

A no-hype OEM formula framework for barrier repair: biomimetic ceramide ratios (3:1:1), Centella asiatica TECA, panthenol B5, bisabolol and ectoin concentration ranges, plus two re

No evidence, no claim. A no-hype guide to cosmetic claim substantiation across FDA MoCRA, EU CPNP and UK SCPN — which claims need human efficacy testing, what it costs, and how an

A no-hype teardown of the Kans Red Waist two-peptide anti-aging formula and what Western skincare OEM buyers can actually replicate. Evidence notes on GHK-Cu and Argireline include

A supply-chain guide to launching a mature skin private label line: MOQ and cost benchmarks, peptide and retinoid formulation limits, MoCRA and EU 1223/2009 compliance, and how to

A quote from an OEM skincare manufacturer is never one number — it is a stack of line items. Eight questions that expose hidden cosmetic manufacturing cost, MOQ math, MoCRA and CPN

A factory offers you a 'free formula' — what's the catch? Who owns the formula IP? What if packaging MOQ is 10,000 but you only need 500 units of product? We answer the 8 advanced

After the Start-of-Autumn solar term, searches for 'AM Protect / PM Repair' jumped 340%. Seasonal flushing, ceramide concentration, and OEM minimum order quantity were this week's

Seasonal barrier care is outgrowing the acid-and-retinoid routine. This guide breaks down the AM Protect / PM Repair architecture, the ceramide 3:1:1 ratio, the real evidence grade

The US has no separate legal category for children's cosmetics — which means the entire safety burden lands on your substantiation file. The EU does have one, and it bans preservat

The post-procedure repair market is booming, but the claim 'use after laser' is a regulatory tripwire in every Western market. This guide breaks down the four-layer repair formula

Most first-time DTC founders sign a two-page OEM agreement without checking who owns the formula or who holds the MoCRA facility registration. Here are the 8 clauses that decide wh

Bifida Ferment Lysate is the core repair base behind Estée Lauder Advanced Night Repair and Lancôme Génifique — a probiotic ferment that rebuilds the skin barrier and rebalances th

Pro-Xylane boosts glycosaminoglycan (GAG) synthesis — including hyaluronic acid — to plump the dermis from within. With L'Oréal's core patent expired in 2024, ingredient costs coll

Real answers on MOQ, MoCRA facility registration, EU CPNP, factory vetting and launch timelines for brands using a private label cosmetics manufacturer in China. No hype, just what

Four beauty trends are driving Q4 2026 briefs for DTC and Amazon brands: cooling formulations, PDRN, multi-peptide systems and clinical-grade body care. Here is the evidence grade

Azelaic acid tackles acne, post-acne marks and rosacea redness in one molecule — and it is tolerated by sensitive skin. Here is the evidence, the workable concentrations, the US an

A multi-pathway brightening formula framework for DTC and Amazon brands: evidence-graded concentrations for niacinamide, tranexamic acid and 3-O-ethyl ascorbic acid, plus MoCRA/EU

Amazon, Shopify DTC, TikTok Shop and Temu each demand a different MOQ, margin structure and compliance file. A channel-by-channel breakdown to help you choose the right private lab

Sampling decides about 80% of whether your product succeeds. This guide breaks down the 7-step cosmetic OEM sampling process — lead times, cost ranges, a 5-point evaluation scoreca

Daily-chemical factories, supplement brands, hotels, and apparel labels are all entering skincare in 2026. This guide compares 7 industries with cost models and compliance checklis

Bakuchiol is the plant-derived retinol alternative US and EU brands are racing to formulate. Sensitive-skin friendly, pregnancy-safe, and morning-compatible — here is what OEM buye